Future Horizons and Growth Strategiesin the US Tumor Marker Testing Market 20154: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategiesin the US Tumor Marker Testing Market 20154: Supplier Shares and Country Forecasts

Category : Diagnostic and Biotech
Published On : June  2015
Pages : 620



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Complete report $8,900.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.

Highlights

  • Comprehensive 620-page analysis of the US tumor marker testing market.
  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
  • Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices.
  • Placements and installed base of automated and semi-automated analyzers used for tumor marker testing.
  • Current instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 620 pages and 103 tables

image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.